The Liver Meeting 2026
Talk TLM Theater track
The Evolving Treatment Landscape for Adults with MASH: Results from a Phase 3 Trial
Sat, Nov 7, 2026 · 1:30–2:00 PM MST Convention Center: TLM Theater 2, Hall F, Colorado Convention Center
About this session
Join us for a focused look at clinical data from a phase 3 trial, detailing the 72-week efficacy and safety of a treatment for adults with noncirrhotic MASH and moderate to advanced fibrosis. The session will outline how these results may support care for appropriate patients with this chronic liver disease. Industry Supporter: Novo Nordisk, Inc.
